Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$20.73
+0.24%today
MKT CAP
$1.4B
+22.6% · 1Y
Earnings History
+21.1%
-59.8%
+39.3%
+3.3%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$20.73
Low
$14.10
Analyst Mean
$39.70
High
$95.69
11 analystsBuy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-7.5x
Price/Sales-
Dividend Yield-
Revenue Growth YoY+6.6%
Earnings Growth YoY-
Revenue Growth QoQ-35.4%
5y Revenue CAGR-48.7%
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin-900.9%
Net Margin0.0%
ROE-207.1%
Debt / Equity269.78x
Free Cash Flow$-106,758,000
Insider Ownership5.6%
Institutional Ownership102.8%
Short % of Float17.87%
Days to Cover6.2d
1 Week+14.9%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| KAPUSTA MATTHEW C | Chief Executive Officer | Stock | 70,600 | $0.00 | $0.00M | 2026-03-04 |
| KAPUSTA MATTHEW C | Chief Executive Officer | Sale | 14,581 | $9.06 | $0.13M | 2026-03-04 |
| KLEMT CHRISTIAN | Chief Financial Officer | Stock | 39,600 | $0.00 | $0.00M | 2026-03-04 |
| KLEMT CHRISTIAN | Chief Financial Officer | Sale | 12,000 | $9.06 | $0.11M | 2026-03-04 |
| POTTS JEANNETTE | Officer | Stock | 35,400 | $0.00 | $0.00M | 2026-03-04 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| FMR, LLC | institution | 9.98% | $0.17B | +2.99% | 2025-12-31 |
| Avoro Capital Advisors LLC | institution | 9.84% | $0.17B | +38.38% | 2025-12-31 |
| Aberdeen Group plc | institution | 8.49% | $0.15B | +44.25% | 2026-03-31 |
| RTW Investments LP | institution | 5.94% | $0.10B | -16.12% | 2025-12-31 |
| State Street Corporation | institution | 5.17% | $0.09B | +123.75% | 2025-12-31 |
| JPMORGAN CHASE & CO | institution | 4.69% | $0.08B | +27.66% | 2025-12-31 |
| Blackrock Inc. | institution | 3.16% | $0.05B | +36.57% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | fund | 2.84% | $0.05B | -35.72% | 2026-03-31 |
| abrdn Healthcare Investors | fund | 2.42% | $0.04B | +5.86% | 2025-12-31 |
| Two Sigma Investments, LP | institution | 2.32% | $0.04B | +61.70% | 2025-12-31 |
| MPM Bioimpact LLC | institution | 2.21% | $0.04B | +100.00% | 2025-12-31 |
| Jennison Associates LLC | institution | 1.97% | $0.03B | -10.02% | 2026-03-31 |
| abrdn World Healthcare Fund | fund | 1.58% | $0.03B | +32.48% | 2025-12-31 |
| abrdn Life Sciences Investors | fund | 1.11% | $0.02B | +5.46% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 1.08% | $0.02B | +3.57% | 2025-12-31 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | fund | 1.04% | $0.02B | +0.00% | 2026-03-31 |
| J.P. Morgan Mutual Fd. Investment TRT-JPMorgan Growth Advantage Fd. | fund | 0.94% | $0.02B | +100.00% | 2025-12-31 |
| JPMorgan Trust II-JPMorgan Mid Cap Growth Fund | fund | 0.91% | $0.02B | +100.00% | 2025-12-31 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | fund | 0.80% | $0.01B | +100.00% | 2025-12-31 |
| abrdn Healthcare Opportunities Fund | fund | 0.77% | $0.01B | +365.59% | 2025-12-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for QURE.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.